Study of the Efficacy and Safety of Inhaled | Clinical Research Studies Listing

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis

Recruiting

40 years - 99 years

All

Phase N/A

1 Location

Brief description of study

This study is looking to see if inhaled treprostinil helps patients with IPF improve their pulmonary function tests. Patients will randomized to either placebo or inhaled treprostinil and will also undergo the following throughout the study: PFTs, physical exams, EKGs, HRCT, questionnaires, vital signs, lab tests

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Pulmonary Fibrosis
Age: 40 years - 99 years
Gender: All

Male or Female Over 40 Years of age Idiopathic Pulmonary Fibrosis

Updated on 04 Aug 2024. Study ID: 849703

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis

Brief description of study

Eligibility of study

Find a site

Interested in the study